Log in

Avelumab

Hyperprogression of merkel cell carcinoma: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Thailand)

Instant access to the full article PDF.

Reference

  • Pirker R, et al. Hyperprogression of Merkel cell carcinoma after avelumab treatment. Journal of the European Academy of Dermatology and Venereology 37: e675-e677, No. 5, May 2023. Available from: URL: http://doi.org/10.1111/jdv.18887

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Avelumab. Reactions Weekly 1968, 60 (2023). https://doi.org/10.1007/s40278-023-44224-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-44224-4

Navigation